25-Hydroxycholesterol has a dual effect on the proliferation of cultured rat astrocytes

被引:11
作者
Velazquez, Esther
Santos, Antonio
Montes, Agustin
Blazquez, Enrique
Ruiz-Albusac, Juan Miguel [1 ]
机构
[1] Univ Complutense, Fac Med, Dept Biochem & Mol Biol 3, E-28040 Madrid, Spain
[2] Univ Complutense Madrid, Fac Biol, Dept Microbiol, Madrid, Spain
[3] Univ Alcala de Henares, Dept Physiol, Madrid, Spain
关键词
oxysterols; astrocytes; statins; cell growth; cell cycle; gene expression;
D O I
10.1016/j.neuropharm.2006.03.017
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We examined the effects of 25-OH-cholesterol on the growth of cultured rat astrocytes in the presence of lipoprotein-deficient serum (LPDS). 25-OH-cholesterol at 0.5-8 mu M induced an increase in DNA synthesis as measured by [H-3]thymidine incorporation into DNA, staining the cells with crystal violet, or counting the number of cells in different phases of the cell cycle by flow cytometry; however, at higher doses, an inhibition of cell proliferation was produced. Similar dose-dependent effects were found in media containing albumin (alone or with added EGF, PDGF, IGF-I or insulin), fetal bovine serum (FBS), or cholesterol-enriched LPDS. Mevalonate, and partially 25-OH-cholesterol, reversed the decrease in cell viability caused by mevinolin (lovastatin). However, mevalonate did not have any effect on 25-OH-cholesterol-stimulated proliferation. Finally, in media with albumin alone or in the presence of fetal bovine serum, growth factors, insulin or forskolin, 25-OH-cholesterol did not affect the expression of either c-fos mRNA or c-fos protein, as measured by real-time quantitative PCR or by Western blot, respectively. These results suggest that 25-OH-cholesterol has a dual effect on the proliferation of cultured rat astrocytes through an AP-1-independent mechanism. This could be of interest for gaining a better knowledge of the pathophysiological processes occurring in these cells. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:229 / 237
页数:9
相关论文
共 25 条
  • [1] BOCHELEN D, 1995, J NEUROCHEM, V65, P2194
  • [2] The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
    Brown, MS
    Goldstein, JL
    [J]. CELL, 1997, 89 (03) : 331 - 340
  • [3] BROWN MS, 1974, J BIOL CHEM, V249, P7306
  • [4] CHAKRABARTI R, 1991, J BIOL CHEM, V266, P12216
  • [5] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [6] New views on cholesterol in the central nervous system
    Claudepierre, T
    Pfrieger, FW
    [J]. M S-MEDECINE SCIENCES, 2003, 19 (05): : 601 - 605
  • [7] FIELD FJ, 1991, J LIPID RES, V32, P1811
  • [8] Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Aβ levels
    Fukumoto, H
    Deng, A
    Irizarry, MC
    Fitzgerald, ML
    Rebeck, GW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) : 48508 - 48513
  • [9] Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts:: Involvement of nonsterol isoprenoid biosynthesis inhibition
    García-Román, N
    Alvarez, AM
    Toro, MJ
    Montes, A
    Lorenzo, MJ
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2001, 17 (02) : 329 - 341
  • [10] EFFECT OF LOVASTATIN ON THE DEVELOPMENT OF POLYCYSTIC KIDNEY-DISEASE IN THE HAN-SPRD RAT
    GILE, RD
    COWLEY, BD
    GATTONE, VH
    ODONNELL, MP
    SWAN, SK
    GRANTHAM, JJ
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (03) : 501 - 507